Theravance Biopharma (TBPH) Return on Capital Employed [ROCE] (2014 - 2026)
Theravance Biopharma (TBPH) posted Return on Capital Employed [ROCE] of -0.95% for Q2 2026, up 10.31 percentage points from -11.27% a year earlier but down 1.26 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Theravance Biopharma's Return on Capital Employed [ROCE] came in at -0.94%, up 13.03 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +93.43 percentage points (FY2020 to FY2025).
- In prior years, Theravance Biopharma's Return on Capital Employed [ROCE] was -13.97% in FY2024 (-2.05 pp), -11.92% in FY2023 (+7.96 pp), -19.89% in FY2022 (+51.06 pp) and -70.95% in FY2021 (+23.43 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -79.44% in Q3 2021 to a high of 0.30% in Q1 2026 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +5.71 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2022, with a gain of 64.03 percentage points; the weakest was Q3 2021, with a drop of 12.19 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 0.30% (Q1 2026), -0.87% (Q4 2025) and -8.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -0.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.95% |
| Mar 31, 2026 | 0.30% |
| Dec 31, 2025 | -0.87% |
| Sep 30, 2025 | -8.56% |
| Jun 30, 2025 | -11.27% |
| Mar 31, 2025 | -15.81% |
| Dec 31, 2024 | -14.53% |
| Sep 30, 2024 | -13.11% |
| Jun 30, 2024 | -12.19% |
| Mar 31, 2024 | -11.92% |
| Dec 31, 2023 | -15.02% |
| Sep 30, 2023 | -16.61% |
| Jun 30, 2023 | -14.45% |
| Mar 31, 2023 | -14.33% |
| Dec 31, 2022 | -14.00% |
| Sep 30, 2022 | -31.12% |
| Jun 30, 2022 | -53.82% |
| Mar 31, 2022 | -66.19% |
| Dec 31, 2021 | -78.03% |
| Sep 30, 2021 | -79.44% |
API Access
Theravance Biopharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();